Holen Sie sich die Stockscreener-App
1.47
3.92%
-0.06
Vorhandelsmarkt:
1.62
0.15
+10.20%
Schlusskurs vom Vortag:
$1.53
Offen:
$1.46
24-Stunden-Volumen:
403.71K
Relative Volume:
0.03
Marktkapitalisierung:
$58.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.34M
KGV:
-2.109
EPS:
-0.697
Netto-Cashflow:
$-15.59M
1W Leistung:
+3.52%
1M Leistung:
+2.08%
6M Leistung:
+5.00%
1J Leistung:
-26.13%
1-Tages-Spanne:
$1.42
$1.505
1-Wochen-Bereich:
$1.40
$1.5761
52-Wochen-Spanne:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Firmenname
Heartbeam Inc
Sektor
Branche
Telefon
408-899-4443
Adresse
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.47 | 61.38M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
185.91 | 29.83B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.40 | 9.53B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
40.65 | 7.50B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
80.43 | 6.66B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.58 | 5.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-31 | Eingeleitet | Roth Capital | Buy |
| 2020-09-11 | Eingeleitet | Needham | Buy |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-08-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-07-26 | Bestätigt | Lake Street | Buy |
| 2018-04-26 | Bestätigt | The Benchmark Company | Buy |
| 2018-02-23 | Bestätigt | Dougherty & Company | Buy |
| 2017-11-08 | Bestätigt | Dougherty & Company | Buy |
| 2017-10-26 | Eingeleitet | Raymond James | Outperform |
| 2017-10-24 | Eingeleitet | SunTrust | Buy |
| 2017-08-09 | Bestätigt | Dougherty & Company | Buy |
| 2017-07-19 | Bestätigt | The Benchmark Company | Buy |
| 2017-04-11 | Bestätigt | Dougherty & Company | Buy |
| 2016-12-02 | Eingeleitet | Dougherty & Company | Buy |
| 2016-09-13 | Eingeleitet | Sidoti | Buy |
| 2016-08-03 | Bestätigt | The Benchmark Company | Buy |
| 2015-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2013-10-24 | Eingeleitet | The Benchmark Company | Buy |
| 2013-08-21 | Eingeleitet | Dougherty & Company | Buy |
Alle ansehen
Heartbeam Inc Aktie (BEAT) Neueste Nachrichten
HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target - Digital Journal
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform - Digital Journal
BEAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - USA Today
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - USA Today
Risk On: Is SQNS stock a hidden gemMarket Sentiment Report & Daily Entry Point Alerts - baoquankhu1.vn
HeartBeam (BEAT) Price Target Increased by 16.22% to 5.48 - Nasdaq
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - USA Today
Breakout Move: What are HeartBeam Inc Equity Warrants recent SEC filings showingEarnings Growth Report & Smart Money Movement Alerts - baoquankhu1.vn
Will HeartBeam Inc. benefit from rising consumer demand2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
HeartBeam (BEAT) Showcased for Advancing Innovative ECG Platform - NewMediaWire
Will HeartBeam Inc. stock attract more institutional investorsWeekly Investment Summary & Smart Swing Trading Techniques - mfd.ru
HeartBeam’s Portable ECG Is Cleared, But Cash Is Tight - Finimize
HeartBeam Earns FDA Clearance for 12-Lead Synthesis Software for Assessing Arrhythmia - Diagnostic and Interventional Cardiology
Can HeartBeam Inc. stock deliver consistent earnings growth2025 Technical Overview & Technical Entry and Exit Alerts - mfd.ru
What is HeartBeam Inc.’s book value per shareTreasury Yields & Risk Managed Investment Strategies - mfd.ru
Why HeartBeam Inc. stock is considered a top pickJuly 2025 Institutional & High Accuracy Swing Entry Alerts - mfd.ru
Jobs Data: Is HeartBeam Inc a turnaround storyPortfolio Update Report & Long-Term Investment Growth Plans - baoquankhu1.vn
HeartBeam (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - The Globe and Mail
HeartBeam (BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - Yahoo Finance
Can HeartBeam Inc. outperform in the next rallyTrade Ideas & High Conviction Buy Zone Picks - mfd.ru
Is HeartBeam Inc. a strong candidate for buy and holdSwing Trade & Stepwise Entry and Exit Trade Signals - mfd.ru
What analysts say about HeartBeam Inc. stockJuly 2025 Weekly Recap & Real-Time Market Trend Scan - mfd.ru
Can HeartBeam Inc. Equity Warrant be recession proof2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - mfd.ru
HeartBeam (BEATW) Stock Analysis Report | Financials & Insights - Benzinga
HeartBeam Files $100 Million Mixed Shelf - marketscreener.com
Is HeartBeam Inc. Equity Warrant stock undervalued vs historical averagesWeekly Investment Recap & Real-Time Buy Signal Alerts - mfd.ru
Bryan Humbarger Named Chief Commercial Officer at HeartBeam - Medical Product Outsourcing
Aug Patterns: Can HeartBeam Inc deliver alpha2025 Price Momentum & High Return Trade Guides - baoquankhu1.vn
Market Recap: Does HeartBeam Inc Equity Warrant have pricing powerRecession Risk & Advanced Technical Signal Analysis - baoquankhu1.vn
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
Trend Review: Does HeartBeam Inc Equity Warrant have pricing power2025 Earnings Surprises & Detailed Earnings Play Alerts - baoquankhu1.vn
HeartBeam names Bryan Humbarger as CCO - Medical Buyer
US Market Wrap: How volatile is Empire State Realty OP LP Limited Partnership stockJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
HeartBeam appoints Bryan Humbarger as chief commercial officer By Investing.com - Investing.com Nigeria
HeartBeam (BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - NewMediaWire
Meme Stocks: Is CTGO on track to beat earningsTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
Heartbeam, Inc. Appoints Bryan Humbarger as Chief Commercial Officer, Effective January 22, 2026 - marketscreener.com
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - 01net
HeartBeam appoints Bryan Humbarger as chief commercial officer - Investing.com
Sectors Review: Can HeartBeam Inc maintain its current growth rate2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Review: Is GSR III Acquisition Corp. showing insider buyingWeekly Stock Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Activity Recap: How does Roper Technologies Inc perform in inflationary periodsMarket Trend Review & Breakout Confirmation Alerts - baoquankhu1.vn
Dow Update: Should value investors consider HeartBeam IncJuly 2025 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Recap Report: Can HeartBeam Inc Equity Warrant stock sustain revenue growthPortfolio Gains Report & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Aug Gainers: Should value investors consider HeartBeam Inc2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - TradingView — Track All Markets
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
Finanzdaten der Heartbeam Inc-Aktie (BEAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.75%
4.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):